At Ivim Health, we believe patients deserve access to innovative care through qualified physicians, licensed pharmacies, and evidence-based medicine. That’s why our Chief Medical Officer, Dr. Jessica Duncan, testified before the FDA’s Pharmacy Compounding Advisory Committee (PCAC) in Washington, D.C. on July 23, … Read more
A federal advisory committee has recommended making BPC-157, a peptide popular in online wellness and fitness circles, available again through licensed compounding pharmacies. The FDA’s Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157 to the 503A … Read more
Anthony Kantor, Dr. Taylor Kantor, and Dr. Jessica Duncan — We applaud today’s announcement from Secretary Kennedy on peptide reclassification. This is meaningful news for the patients we serve every day. For too long, Americans interested in peptide therapy have had limited options … Read more
By now, most Americans have heard of semaglutide and tirzepatide — the GLP-1 medications sold under names like Ozempic, Wegovy, and Zepbound. What fewer people know is what these drugs actually are at a biological level: peptides. … Read more
